Price loading...

The 2025-2030 World Outlook for Hypertrophic Cardiomyopathy Therapeutics

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics
99% match

The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics

£790.00 11 Jan 2026
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
98% match

The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics

£790.00 23 Jan 2026
The 2025-2030 World Outlook for Sepsis Therapeutics
97% match

The 2025-2030 World Outlook for Sepsis Therapeutics

£790.00 24 Jan 2026
The 2025-2030 World Outlook for Hypertension Management Devices
97% match

The 2025-2030 World Outlook for Hypertension Management Devices

£790.00 11 Jan 2026
2025-2030 World Outlook - Implantable Cardiac Rhythm Devices
97% match

2025-2030 World Outlook - Implantable Cardiac Rhythm Devices

£790.00 09 Mar 2026
The 2025-2030 World Outlook for Hydroxychloroquine
97% match

The 2025-2030 World Outlook for Hydroxychloroquine

£790.00 26 Jan 2026
The 2025-2030 World Outlook for Telmisartan
97% match

The 2025-2030 World Outlook for Telmisartan

£790.00 24 Jan 2026
The 2025-2030 World Outlook for Temporary Cardiac Pacing Leads
97% match

The 2025-2030 World Outlook for Temporary Cardiac Pacing Leads

£790.00 02 Feb 2026
The 2025-2030 World Outlook for Hydroxychloroquine Sulphates
96% match

The 2025-2030 World Outlook for Hydroxychloroquine Sulphates

£790.00 31 Jan 2026
The 2025-2030 World Outlook for T-Cell Therapies
96% match

The 2025-2030 World Outlook for T-Cell Therapies

£790.00 31 Jan 2026
The 2025-2030 World Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs
96% match

The 2025-2030 World Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs

£790.00 26 Jan 2026
The 2025-2030 World Outlook for Digital Therapeutics Sales
96% match

The 2025-2030 World Outlook for Digital Therapeutics Sales

£790.00 09 Mar 2026
The 2025-2030 World Outlook for Implantable Pacemakers
96% match

The 2025-2030 World Outlook for Implantable Pacemakers

£790.00 27 Jan 2026
The 2025-2030 World Outlook for Testosterone Replacement Therapies
96% match

The 2025-2030 World Outlook for Testosterone Replacement Therapies

£790.00 22 Jan 2026
The 2025-2030 World Outlook for Testosterone Replacement Therapy for Male Hypogonadism
96% match

The 2025-2030 World Outlook for Testosterone Replacement Therapy for Male Hypogonadism

£790.00 28 Jan 2026
The 2025-2030 World Outlook for Hyperbaric Oxygen Therapy Devices
96% match

The 2025-2030 World Outlook for Hyperbaric Oxygen Therapy Devices

£790.00 17 Mar 2026
The 2025-2030 World Outlook for Hydrazine Hydrates
96% match

The 2025-2030 World Outlook for Hydrazine Hydrates

£790.00 26 Jan 2026
The 2025-2030 World Outlook for Nocturia Drugs
96% match

The 2025-2030 World Outlook for Nocturia Drugs

£790.00 27 Jan 2026
The 2025-2030 World Outlook for Nutraceuticals
96% match

The 2025-2030 World Outlook for Nutraceuticals

£790.00 29 Jan 2026
The 2025-2030 World Outlook for Sepsis Drugs
96% match

The 2025-2030 World Outlook for Sepsis Drugs

£790.00 01 Feb 2026
The 2025-2030 World Outlook for Hypothyroidism Treatments
96% match

The 2025-2030 World Outlook for Hypothyroidism Treatments

£790.00 07 Feb 2026
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
96% match

The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis

£790.00 13 Jan 2026
The 2025-2030 World Outlook for Hyperbaric Oxygen Therapy Equipment
96% match

The 2025-2030 World Outlook for Hyperbaric Oxygen Therapy Equipment

£790.00 12 Jan 2026
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
96% match

The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 14 Jan 2026